Del Mar, CA, United States of America

Gilbert M Rishton

This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilbert M Rishton. Retrieved from https://idiyas.com/inventor/gilbert-m-rishton-no6g9hoe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Gilbert M. Rishton

Introduction

Gilbert M. Rishton is a notable inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of immuno-inflammatory diseases. His work has led to the development of novel compounds that hold promise for improving patient outcomes.

Latest Patents

Rishton holds a patent for "Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell." This patent discloses novel substituted naphthyl-, quinolyl-, and isoquinolyl- sulfonamide derivatives that are useful in treating immuno-inflammatory diseases in mammalian patients. The pharmaceutical compositions containing these sulfonamide compounds are also provided, showcasing the potential therapeutic applications of his inventions.

Career Highlights

Gilbert M. Rishton is associated with Tanabe Seiyaku Company, Limited, where he has been instrumental in advancing pharmaceutical research. His innovative approach and dedication to improving healthcare have made him a valuable asset in the industry.

Collaborations

Some of his notable coworkers include Nancy Kay Harn and Wolfgang Scholz. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Gilbert M. Rishton exemplifies the spirit of innovation in the pharmaceutical field. His contributions through patents and collaborations continue to impact the treatment of immuno-inflammatory diseases positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…